Latest in News & Research

Recommendations Updated for Recombinant Zoster Vaccine

Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged...

By Physician’s Briefing Staff | | January 20, 2022

Is Electrical Impedance Spectroscopy Beneficial for Detecting Melanoma?

EIS increases diagnostic confidence for students and dermatologists assessing lesions clinically suspicious for melanoma

By Dermsquared Editorial Team | | January 19, 2022

Does Telemedicine Help to Cut Nonattendance for Dermatology Patients?

Telemedicine linked to substantially reduced nonattendance rates in pediatric patients, but not in patients aged 65 years and older

By Dermsquared Editorial Team | | January 19, 2022

Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis

Dermatologists and patients with psoriatic disease approve of a specialist-led model of care

By Physician’s Briefing Staff | | January 19, 2022

FDA Approves Rinvoq for Treatment of Atopic Dermatitis

Approval indicated for those 12 years and older with atopic dermatitis that has not responded to previous treatment

By Physician’s Briefing Staff | | January 19, 2022

Is Nemolizumab Beneficial for Atopic Dermatitis, Concomitant Pruritus?

Patients on nemolizumab reported improvements in pruritus visual analog scale, Eczema Area and Severity Index, and quality-of-life indicators

By Dermsquared Editorial Team | | January 12, 2022

Cutaneous Immune-Related AEs Linked to Survival After ICI Therapy

Improved survival associated with cirAEs for patients receiving anti-programmed cell death 1 or anti-programmed cell death ligand 1 therapy

By Dermsquared Editorial Team | | January 12, 2022

Depression Up in Pediatric, Adult Hidradenitis Suppurativa Patients

Prevalence of depression increased among adults and children with hidradenitis suppurativa

By Physician’s Briefing Staff | | January 12, 2022

Pfizer Says Omicron-Specific Vaccine Ready by March

Pfizer also working to improve its current COVID-19 vaccine 'to address any future variant of potential concern, if needed'

By Physician’s Briefing Staff | | January 12, 2022

Severe COVID-19 Outcomes Rare After Primary Vaccination

Risk higher for people who were aged 65 years or older, immunosuppressed, or had at least one of six underlying conditions

By Physician’s Briefing Staff | | January 10, 2022

Relatlimab-Nivolumab Ups PFS in Untreated Advanced Melanoma

Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma

By Physician’s Briefing Staff | | January 06, 2022

Secukinumab Beneficial for Psoriatic Arthritis, Concomitant Plaque Psoriasis

Significantly more patients receiving secukinumab versus adalimumab achieved PASI 100 response at week 52

By Dermsquared Editorial Team | | January 05, 2022

How Satisfied Are Patients With Clinic-Based Hidradenitis Suppurativa Surgery?

Despite recurrence, most patients with hidradenitis suppurativa are very satisfied with their surgical results

By Dermsquared Editorial Team | | January 05, 2022

Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race

Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs

By Physician’s Briefing Staff | | January 05, 2022

Serious Adverse Effects From COVID-19 Vaccines Reported Rarely

Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects

By Physician’s Briefing Staff | | January 05, 2022

Atopic Dermatitis Exacerbations Seen in Premenstrual Period

Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index

By Physician’s Briefing Staff | | January 05, 2022

Scientists Spot Clues to Why Omicron Infections Are Milder

More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month

By Physician’s Briefing Staff | | January 03, 2022

Is Ultrasonography More Sensitive for Detecting Metastases in High-Risk SCC?

Baseline ultrasonography more sensitive for detecting lymph node metastases than clinical examination alone

By Dermsquared Editorial Team | | December 29, 2021

Is Apremilast Efficacious, Safe for Mild-to-Moderate Psoriasis?

Significantly greater response rate seen in static Physician Global Assessment at week 16 for apremilast versus placebo

By Dermsquared Editorial Team | | December 29, 2021

High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy

Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade

By Physician's Briefing Staff | | December 28, 2021

Spesolimab Clears Lesions in Generalized Pustular Psoriasis

In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions

By Physician’s Briefing Staff | | December 27, 2021

AI Allows Automated Scoring of Psoriasis Area, Severity

Conventional neural networks have the potential to automatically perform image-based Psoriasis Area and Severity Index scoring

By Physician’s Briefing Staff | | December 24, 2021

Botox Injections Linked to Lower Incidence of Anxiety Symptoms

Protective effect of BoNT found for different indications, including in cosmetic use/facial muscles, migraine/facial and head muscles

By Physician’s Briefing Staff | | December 23, 2021

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026